A detailed history of Gamma Investing LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Gamma Investing LLC holds 583 shares of UTHR stock, worth $211,774. This represents 0.02% of its overall portfolio holdings.

Number of Shares
583
Previous 390 49.49%
Holding current value
$211,774
Previous $124 Million 68.16%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$311.04 - $363.55 $60,030 - $70,165
193 Added 49.49%
583 $209 Million
Q2 2024

Jul 02, 2024

BUY
$228.26 - $319.04 $40,858 - $57,108
179 Added 84.83%
390 $124 Million
Q1 2024

Apr 05, 2024

BUY
$210.76 - $249.51 $2,529 - $2,994
12 Added 6.03%
211 $48.5 Million
Q4 2023

Feb 01, 2024

BUY
$214.88 - $256.94 $42,761 - $51,131
199 New
199 $42.7 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.